This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Holdaway IM et al. (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89: 667–674
Bevan JS et al. (2002) Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 87: 4554–4563
Hofland LJ and Lamberts SW (2003) The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24: 28–47
Jacquet P et al. (2000) Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid and hormone suppression identify different tumoral phenotypes. J Clin Endocrinol Metab 85: 781–792
Matrone C et al. (2004) Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs. Neuroendocrinology 79: 142–148
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Hoffman is on the Scientific Advisory Board of Genentech and Ambrx; a consultant for Genentech, LG Life Sciences, Teva and ConjuChem; has been awarded research grants by Genentech and Pfizer; holds honoraria from Genentech and Pfizer; and owns stock in Ambrx.
Rights and permissions
About this article
Cite this article
Hoffman, A. Partial tumor debulking enhances the response to somatostatin analogs in acromegaly. Nat Rev Endocrinol 2, 424–425 (2006). https://doi.org/10.1038/ncpendmet0223
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0223